Lord, Abbett & Co’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$3.17M Buy
2023
Q3
Sell
2023
Q2
$97.3M Buy
2023
Q1
$59.6M Sell
2022
Q4
$58.6M Buy
2022
Q3
$64.6M Buy